September 18-21, 2023|Boston Convention and Exhibition Center, Boston, MA
The Cell, Gene & Immunotherapy Event for Improving Manufacturing Efficiencies, Costs and Quality
Accelerate your bioprocessing, analytics, supply chain security and commercialization strategies by accessing novel science, technologies and the contacts you need
Speaking Proposals Due March 24
Last year was our largest turnout in event history with 2700+ attendees across 36 countries for CGT US and it's co-located event BioProcess International. Highlight your company's novel scientific research and technologies at this year's Cell & Gene Therapy Manufacturing & Commercialization Conference & Exhibition by submitting a speaking proposal today.
Get the Latest Event Updates
Bringing you cutting edge case studies across the cell, gene & immunotherapy spectrum
Below are the main topics of the Cell & Gene Therapy Manufacturing & Commercialization 2022 event.
Cell Therapy
- Discover process optimization and implementation strategies for automated, closed, and integrated systems in autologous cell therapy manufacturing
- Build your analytical toolbox to improve testing, characterization & validation strategies
- Get to grips with raw materials, cryopreservation, and logistical requirements for seamless end to end supply chains
Gene Edited Ex Vivo Cell Therapy
- Hear the latest scale up strategies for robust manufacturing of next generation “off the shelf” allogeneic and gene edited modalities
- Tackle CAR-Ts, NK cells, TCRs, TILs and iPSCs commercialization with manufacturing and patient delivery models at scale
- Beyond rare diseases: Overcome the challenges of expanding to larger patient populations with cell and gene therapies
In Vivo Gene Therapy
- Hear case studies on how to increase speed, consistency, scalability, and flexibility in gene therapy manufacturing
- Develop analytical toolkits for AAV characterization and understanding CQAs
- Evaluate new technologies to overcome downstream processing and viral clearance challenges
Partnering & Collaborations
- Get a global view on value, regulatory considerations, pricing, and access for novel therapies
- Discover investors views on innovation in the cell and gene therapy space
- Explore best practices for working with CDMOs and suppliers
Cell and Tissue Manufacturing – in collaboration with ARMI
- Generate high quality cellular starting materials with access to the latest harvesting and cell culture expansion technologies
- Hear the latest trends in real-time and online sensors for monitoring cell and tissue attributes during culture, expansion, and maturation
- Discuss cost-effective process development and robust CMC strategies for designing and obtaining commercial approval for tissue and cell based regenerative medicines
Co-located with the BPI Conference & Expo
- Benefit from a conference pass including access to all talks and content across both events
- Maximize networking opportunities with attendees working in MAbs, vaccines & novel biological products
- Connect with leading technology innovators across all phases of biopharmaceutical production and development
Last Year's Cell, Gene & Immunotherapy Thought Leaders
Last year, CGT's scientific agenda included 100+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of Cell & Gene Therapy development and production Below are some of the key speakers who have presented on the CGT US 2022 agenda.
CONNECT WITH KEY BUYERS AT Cell & Gene Therapy 2023
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact Perri Lucatello: PLucatello@informaconnectls.com | +44 208 052 0465